TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pfizer Health AB
Closing information (x1000 NOK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
4,474,055
|
6,482,002
|
4,011,567 |
| Financial expenses |
3,042
|
0
|
947 |
| Earnings before taxes |
2,093,030
|
4,042,793
|
2,549,115 |
| EBITDA |
2,155,902
|
4,049,970
|
2,664,597 |
| Total assets |
8,167,279
|
11,300,954
|
9,134,408 |
| Current assets |
5,636,173
|
8,787,922
|
6,845,600 |
| Current liabilities |
1,168,203
|
1,247,801
|
760,096 |
| Equity capital |
6,746,797
|
9,842,678
|
8,177,160 |
| - share capital |
2,593,978
|
2,622,740
|
2,421,328 |
| Employees (average) |
337
|
340
|
325 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
82.6%
|
87.1%
|
89.5% |
| Turnover per employee |
13,276
|
19,065
|
12,343 |
| Profit as a percentage of turnover |
46.8%
|
62.4%
|
63.5% |
| Return on assets (ROA) |
25.7%
|
35.8%
|
27.9% |
| Current ratio |
482.5%
|
704.3%
|
900.6% |
| Return on equity (ROE) |
31.0%
|
41.1%
|
31.2% |
| Change turnover |
-1,936,864
|
2,136,744
|
952,250 |
| Change turnover % |
-30%
|
49%
|
31% |
| Chg. No. of employees |
-3
|
15
|
14 |
| Chg. No. of employees % |
-1%
|
5%
|
5% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.